New blood pressure drug shows promise in first human tests
NCT ID NCT06501586
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 28 times
Summary
This early study tested a new drug called SGB-3908 in 40 healthy adults and people with mild high blood pressure. The main goal was to check if the drug is safe and how the body processes it after a single dose. Participants were randomly assigned to receive either the drug or a placebo, and researchers monitored side effects and blood pressure-related markers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION,ESSENTIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100083, China
Conditions
Explore the condition pages connected to this study.